Zim Laboratories Limited has informed the Exchange regarding allotment of 4764497 securities pursuant to Preferential Issue at its meeting held on March 13, 2026
ZIMLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 8.0 pts more than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Zim Laboratories has allotted 47.64 lakh equity shares to Florintree Trinex LLP through a preferential issue on a private placement basis. The shares were issued at Rs 73.46 each (a premium of Rs 63.46 over the Rs 10 face value), bringing the total raise to roughly Rs 35 crore in cash. Florintree Trinex LLP, a non-promoter entity, did not hold any shares before and now owns 8.91% of the company post-allotment. Following this, the company's paid-up equity capital has gone up from Rs 48.74 crore to Rs 53.50 crore (share count rose from 4.87 crore to 5.35 crore shares). The new shares will rank equally with existing shares. This follows in-principle approvals from NSE and BSE received on February 27, 2026.
The company has brought in a new institutional investor (Florintree Trinex LLP) holding nearly 9% stake, which signals external confidence but also means existing shareholders face around 9.8% dilution. The Rs 35 crore cash infusion could strengthen the balance sheet for growth or working capital needs.